Worcester / Boston / New York / Maihle / Atlanta / San Diego / /
Company
Ligand / McGraw-Hill / QIAGEN / Pfizer Inc. / Wakeling A.E. / Santa Cruz Biotechnology Inc. / Promega Corp. / BD Biosciences / Fauci A.S. / Bio-Rad / Bio-Rad Laboratories Inc. / IMV / Amersham Biosciences / John Wiley & Sons / /
Country
United States / / /
Event
FDA Phase / /
Facility
Dana-Farber Cancer Institute / University of Massachusetts Medical School Institutional Animal Care / Laboratory Animal Care / University of Massachusetts Medical School / / /
IndustryTerm
protein data bank / cancer therapy / oncogenic v-erbB products / postexposure therapy protocols / chemical inhibitors / antiinflammatory viral products / gene product / treatment of breast cancer / chemical inhibition / chemical interference / /
Harvard Medical School / ErbB / National Institute of Health / Dana-Farber Cancer Institute / SPGF-inducible / Centers for Disease Control and Prevention / Department of Medicine / i.p. administration / Department of Medical Oncology / Association for Assessment and Accreditation of Laboratory Animal Care / ErbB-1 association / University of Massachusetts Medical School / University of Massachusetts Medical School Institutional Animal Care and Use Committee / Dana Foundation / /
Person
James B. Dunbar / Mikyung Kim / Hailin Yang / Nat / Wayne Klohs / Aaron Curns / Sung-Kwon Kim / David Fry / Barrett Rollins / Bernard Moss / Ray Dolin / Miles Brown / Huifen Chen / Keisha Mathurin / Crystal Violet / Pedro A. Reche / / /
Position
WB / representative / /
Product
sodium lactate / CI-1033 / Tarceva / mCK-2b / /
ProvinceOrState
New Jersey / New York / California / Georgia / Massachusetts / /
PublishedMedium
The Journal of Clinical Investigation / Molecular Biology / /
Technology
alpha / gene amplification / Molecular modeling / antibodies / postexposure therapy protocols / DNA synthesis / CAV / chemotherapy / treating cancer / drug development / /